1. ScholarBank@NUS

Kang Tse Siang

rp04250

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Kang Tse Siang
(not current staff)
Variants
Kang, T.-S.
Kang, T.S.
 
Main Affiliation
 
Faculty
 
Email
phakts@nus.edu.sg
 

Publications

Refined By:
Department:  PHARMACY
Author:  Kang, T.S.

Results 1-12 of 12 (Search time: 0.006 seconds).

Issue DateTitleAuthor(s)
1Jan-2010Converting an injectable protein therapeutic into an oral form: Phenylalanine ammonia lyase for phenylketonuriaKang, T.S. ; Wang, L.; Sarkissian, C.N.; Gámez, A.; Scriver, C.R.; Stevens, R.C.
2Jan-2014Current strategies for inhibiting FGFR activities in clinical applications: Opportunities, challenges and toxicological considerationsHo, H.K. ; Yeo, A.H.L.; Kang, T.S. ; Chua, B.T.
3Feb-2014Development of an UPLC-MS/MS method for assaying the enzymatic activity of propionyl coenzyme-A carboxylaseDamavandi, M.D.; Chan, E.C.Y. ; Kraus, J.P.; Ho, P.C.-L. ; Kang, T.S. 
47-Oct-2005Effect of C-terminal amidation on folding and disulfide-pairing of α-conotoxin ImIKang, T.S. ; Vivekanandan, S. ; Jois, S.D.S. ; Kini, R.M. 
5Dec-2011Enzymatic toxins from snake venom: Structural characterization and mechanism of catalysisKang, T.S. ; Georgieva, D.; Genov, N.; Murakami, M.T.; Sinha, M.; Kumar, R.P.; Kaur, P.; Kumar, S.; Dey, S.; Sharma, S.; Vrielink, A.; Betzel, C.; Takeda, S.; Arni, R.K.; Singh, T.P.; Kini, R.M. 
6Nov-2011Evaluation of orally administered PEGylated phenylalanine ammonia lyase in mice for the treatment of PhenylketonuriaSarkissian, C.N.; Kang, T.S. ; Gámez, A.; Scriver, C.R.; Stevens, R.C.
710-Oct-2013Identification of michael acceptor-centric pharmacophores with substituents that yield strong thioredoxin reductase inhibitory character correlated to antiproliferative activityGan, F.-F. ; Kaminska, K.K.; Yang, H.; Liew, C.-Y.; Leow, P.-C.; So, C.-L.; Tu, L.N.L.; Roy, A.; Yap, C.-W. ; Kang, T.-S. ; Chui, W.-K. ; Chew, E.-H. 
820-Mar-2007Protein folding determinants: Structural features determining alternative disulfide pairing in α- and χ/λ-conotoxinsKang, T.S. ; Radić, Z.; Talley, T.T.; Jois, S.D.S. ; Taylor, P.; Kini, R.M. 
9Aug-2006Solution structures of two structural isoforms of CMrVIA χ/ λ-conotoxinKang, T.S. ; Jois, S.D.S. ; Kini, M. 
10Dec-2009Structural aspects of therapeutic enzymes to treat metabolic disordersKang, T.S. ; Stevens, R.C.
11Jul-2009Structural determinants of protein foldingKang, T.S. ; Kini, R.M. 
1220-Apr-2020TOXIN TO LEAD: AN INHIBITOR OF FACTOR XIA ENGINEERED FROM BANDED KRAIT VENOM TOXIN FASXIATOR SHOWED SUPERIOR IN VIVO EFFICACY-SAFETY PROFILE COMPARED TO HEPARINKoh, Cho Yeow ; Li, Aaron Wei Liang ; Chen, Wan ; Kang, Tse Siang ; Leong, Esther Jia En ; Lim, Jasmine Jia Min ; Chan, Mark Yan Yee ; Kini, R Manjunatha